Published in Medical Letter on the CDC and FDA, June 8th, 2003
According to published research from the Netherlands, "Non-Candida albicans Candida species are increasingly being isolated. These species show differences in levels of resistance to antimycotic agents and mortality. Therefore, it is important to be able to correctly identify the causative organism to the species level."
"Identification of C. dubliniensis in particular remains problematic due to the high degree of phenotypic similarity between this species and C. albicans," reported A....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA